𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Hepatic trisegmentectomy for metastatic colorectal cancer

✍ Scribed by Thomas A. Nims

Publisher
John Wiley and Sons
Year
1983
Tongue
English
Weight
204 KB
Volume
24
Category
Article
ISSN
0022-4790

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Radical Hepatic Resections For Metastatic Liver Disease Have Been Infrequently Done And Widely Criticized. Seven Patients Are Evaluated Who Had Trisegmentectomies Performed For Extensive Liver Metastases From Colorectal Primaries. There Was 1 Postoperative Death. Of The 6 Evaluable Patients, 4 (66%) Were Alive At 12 Months. Mean Survival Curently Exceeds 20 Months With The Longest Survivor Alive At 41 Months. Radical Hepatic Resections May Offer This Group Of β€œHopeless” Patients Many Months Of Productive Life.

πŸ“œ SIMILAR VOLUMES

Hepatic expression of ANG2 RNA in metast
Hepatic expression of ANG2 RNA in metastatic colorectal cancer
✍ Minoru Ogawa; Hirofumi Yamamoto; Hiroaki Nagano; Yasuhiro Miyake; Yurika Sugita; πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 697 KB

We examined the RNA content of the gene encoding angiopoietin (Ang)-2, a modifier of angiogenesis, in hepatic metastases of colorectal cancer (CRC) to explore the role of this protein in neovascularization of metastatic foci. Metastatic CRC exhibited notable blood flow and tumor vessel formation at

Hepatic resection following systemic che
Hepatic resection following systemic chemotherapy for metastatic colorectal carcinoma
✍ Wyatt C. Fowler; Burton L. Eisenberg; John P. Hoffman πŸ“‚ Article πŸ“… 1992 πŸ› John Wiley and Sons 🌐 English βš– 384 KB

Increasingly effective systemic chemotherapy has improved responses in patients with previously unresectable colorectal hepatic metastases. In the future, response to chemotherapy may define a new population of patients that may benefit from hepatic resection. A retrospective review to determine the

Systemic therapy for metastatic colorect
Systemic therapy for metastatic colorectal cancer : Current questions
✍ Dan S. Zuckerman; Jeffrey W. Clark πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 204 KB

## Abstract A proliferation of new cytotoxic and biologic agents has led to improved survival in patients with metastatic colorectal cancer (mCRC). The ability of surgery to increase long‐term survival in patients with liver and/or lung metastases also has been firmly established. It has become inc